“…Kappa scores regarding agreement on the articles to be included in the full‐text analysis and those finally chosen were 0.91 and 0.95, respectively ( p < 0.001). Out of a total of 391 records assessed, 26 publications were finally included: six laboratory (Chan et al, ; Costa‐Berenguer et al, ; Gehrke, Aramburú Júnior, Dedavid, & Shibli, ; Sharon, Shapira, Wilensky, Abu‐Hatoum, & Smidt, ; de Souza Júnior et al, ; Tribst, Piva, Shibli, Borges, & Tango, ), two preclinical in vivo (Schwarz, Mihatovic, Golubovic, Becker, & Sager, ; Schwarz, Sahm, Mihatovic, Golubovic, & Becker, ), and 18 clinical publications (Englezos, Cosyn, Koole, Jacquet, & De Bruyn, ; Geremias et al, ; Matarasso et al, ; Nart, de Tapia, Pujol, Pascual, & Valles, ; Pommer et al, ; Ramanauskaite, Becker, Juodzbalys, & Schwarz, ; Romeo et al, ; Sapata, de Souza, Sukekava, Villar, & Neto, ; Schwarz et al, ; Schwarz, John, & Becker, ; Schwarz, John, Mainusch, Sahm, & Becker, ; Schwarz, John, Sahm, & Becker, ; Schwarz, John, Schmucker, Sahm, & Becker, ; Schwarz, Sahm, & Becker, ; Schwarz, Sahm, Iglhaut, et al, ; Suh, Simon, Jeon, Choi, & Kim, ; Thierbach & Eger, ). The two preclinical in vivo publications (Schwarz, Mihatovic, et al, ; Schwarz, Sahm, Mihatovic, et al, ) and the clinical of Romeo et al () and Romeo et al () publications reported on different aspects basically of the same study population.…”